Your search returned 4 results.

Results
	1.	MDM2 regulates dihydrofolate reductase activity through monoubiquitination. [electronic resource] by Maguire, Maria Nield, Paul C Devling, Timothy Jenkins, Rosalind E Park, B Kevin Polański, Radoslaw Vlatković, Nikolina Boyd, Mark T Producer: 20080610 In: Cancer research vol. 68 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	MDM2 promotes cell motility and invasiveness through a RING-finger independent mechanism. [electronic resource] by Polański, Radosław Warburton, Hazel E Ray-Sinha, Arpita Devling, Timothy Pakula, Hubert Rubbi, Carlos P Vlatković, Nikolina Boyd, Mark T Producer: 20101220 In: FEBS letters vol. 584 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	MDM2 interacts with NME2 (non-metastatic cells 2, protein) and suppresses the ability of NME2 to negatively regulate cell motility. [electronic resource] by Polanski, Radoslaw Maguire, Maria Nield, Paul C Jenkins, Rosalind E Park, B Kevin Krawczynska, Karolina Devling, Timothy Ray-Sinha, Arpita Rubbi, Carlos P Vlatkovic, Nikolina Boyd, Mark T Producer: 20110930 In: Carcinogenesis vol. 32 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Loss of MTBP expression is associated with reduced survival in a biomarker-defined subset of patients with squamous cell carcinoma of the head and neck. [electronic resource] by Vlatković, Nikolina El-Fert, Ashraf Devling, Timothy Ray-Sinha, Arpita Gore, David M Rubbi, Carlos P Dodson, Andy Jones, Andrew S Helliwell, Tim R Jones, Terence M Boyd, Mark T Producer: 20110823 In: Cancer vol. 117 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)